As a China-based, globally-focused company, we are interested in working with partners to develop and commercialize our products both inside and outside China. We envision several ways of partnerships and collaboration:

For Greater China markets, we plan to advance our drug candidates through clinical studies and obtain marketing approvals. We are interested in partnering with pharmaceutical companies with strong commercialization and marketing capabilities in China to make our product accessible to patients. 

Outside of Greater China, we are interested in working with pharmaceutical companies through co-development after our products have been advanced through proof-of-concept clinical studies.

We also welcome early discovery collaborations to explore novel approaches in drug discovery and to leverage our technology platform of T cell modulation.

To initiate a partnership discussion, please contact Chris Song at

TEL/FAX: 0512-53577866


ADD: Science and Technology Park, East R&D Building , 3rd Floor , 6 Beijing West Road, Taichang, Jiangsu, China 215400

Copyright: Suzhou Connect Biopharmaceuticals, Ltd. 苏ICP备17002143号

Technical support: Epower